Yap Yee Guan, Duong Trinh, Bland J Martin, Malik Marek, Torp-Pederson Christian, Køber Lars, Connolly Stuart J, Gallagher Mark M, Camm A John
Department of Cardiological Sciences, St George's Hospital Medical School, London, UK.
J Hypertens. 2007 Feb;25(2):307-13. doi: 10.1097/HJH.0b013e3280115bae.
The prognostic value of blood pressure measured during hospitalization after acute myocardial infarction (MI) has not been investigated, particularly with regard to arrhythmic death.
A total of 3311 placebo patients (2612 men, median age 64 years; range 23-92) from the EMIAT, CAMIAT, SWORD, TRACE and DIAMOND-MI studies with left ventricular ejection fraction less than 40% or asymptomatic ventricular arrhythmia surviving more than 45 days after MI were pooled. Systolic and diastolic blood pressures and pulse pressures were measured soon after MI (median 6 days, range 0-53 days). Mortality up to 2 years was examined using Cox regression.
At the 2-year follow-up, after adjustment for age, sex, smoking, previous MI, hypertension, heart rate, New York Heart Association functional class, baseline treatments, study effect and diastolic blood pressure, reduced systolic blood pressure measured during hospitalization after acute MI significantly increased the risk of all-cause mortality [hazard ratio (HR) for 10% increase in systolic blood pressure 0.80, 95% confidence interval (CI) 0.71-0.90; P < 0.001] and arrhythmic mortality (HR 0.73, 95% CI 0.61-0.86; P = 0.001). Reduced diastolic blood pressure significantly increased the risk of all-cause mortality (HR 0.87, 95% CI 0.77-0.98; P = 0.02) and arrhythmic mortality (HR 0.80, 95% CI 0.68-0.93; P = 0.005).
In post-MI patients with left ventricular ejection fraction less than 40% or asymptomatic ventricular arrhythmia, reduced blood pressure measured during hospitalization after MI significantly predicts all-cause mortality and arrhythmic mortality, and can be reliably used to identify patients who are at risk of dying after MI.
急性心肌梗死(MI)后住院期间测量的血压的预后价值尚未得到研究,尤其是关于心律失常性死亡方面。
汇总了来自EMIAT、CAMIAT、SWORD、TRACE和DIAMOND - MI研究的3311名安慰剂组患者(2612名男性,中位年龄64岁;范围23 - 92岁),这些患者左心室射血分数低于40%或有无症状性室性心律失常,且在MI后存活超过45天。在MI后不久(中位时间6天,范围0 - 53天)测量收缩压、舒张压和脉压。使用Cox回归分析2年内的死亡率。
在2年随访时,在调整了年龄、性别、吸烟、既往MI、高血压、心率、纽约心脏协会功能分级、基线治疗、研究效应和舒张压后,急性MI后住院期间收缩压降低显著增加全因死亡率风险[收缩压每升高10%的风险比(HR)为0.80,95%置信区间(CI)0.71 - 0.90;P < 0.001]和心律失常性死亡率(HR 0.73,95% CI 0.61 - 0.86;P = 0.001)。舒张压降低显著增加全因死亡率风险(HR 0.87,95% CI 0.77 - 0.98;P = 0.02)和心律失常性死亡率(HR 0.80,95% CI 0.68 - 0.93;P = 0.005)。
在左心室射血分数低于40%或有无症状性室性心律失常的MI后患者中,MI后住院期间测量的血压降低显著预测全因死亡率和心律失常性死亡率,并可可靠地用于识别MI后有死亡风险的患者。